Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
GSK to SCOTUS: Don't take up 'skinny' generic drug label case
3 years ago
Pharma
Fewer than 40% of new accelerated approvals demonstrate 'high' therapeutic value, study says
3 years ago
FDA+
Endo loses Vasostrict patent battle as sales take a hit from generics
3 years ago
Pharma
New Jersey judge decides Bausch Health's Xifaxan is 'prior art,' does not infringe Curia patents
3 years ago
Pharma
Endo files for Chapter 11 as it looks to finish off its opioid litigation
3 years ago
Pharma
President Biden signs major drug pricing reforms into law: What's coming for biopharma?
3 years ago
Pharma
Zantac litigation: One suit down, many more to go, GSK says
3 years ago
AstraZeneca files lawsuit against former exec as he jumps to GSK
3 years ago
People
Pharma
French pharma exec says he lied to FDA in attempt to steal a Novartis weight loss drug
3 years ago
Pharma
House passes historic drug pricing reforms, lining up decades-in-the-making win for Biden and Democrats
3 years ago
Senate Finance chair continues his investigation into pharma taxes with requests for Amgen
3 years ago
Pharma
Paving the way for Merck's buyout, Seagen loses arbitration dispute with Daiichi Sankyo over ADC tech
3 years ago
Pharma
Blasting 'speculative commentary,' GSK offers update on Zantac litigation and vows to 'vigorously defend itself'
3 years ago
Pharma
Sanofi, GSK, Haleon see stock prices dip and dive amid litigation for recalled heartburn drug
3 years ago
Pharma
Major drug price reforms head for Biden's signature as PhRMA weighs legal options
3 years ago
Pharma
Faced with thousands of opioid lawsuits, Endo says it will likely file for bankruptcy 'imminently'
3 years ago
Pharma
With drug pricing almost done, Congress looks to wrap up FDA user fee legislation
3 years ago
FDA+
Senate Dems cling to a simple majority to pass some of the biggest drug pricing reforms ever
3 years ago
Pharma
Prosecutors fail to extend ex-GSK scientists' sentences in trade secrets case
3 years ago
Pharma
'What’s wrong with having lots of patents?' Federal appeals judge sides with AbbVie in Humira case
3 years ago
Pharma
AbbVie's Allergan inks $2.3B+ opioid settlement with several states
3 years ago
Pharma
Bausch Health asserts push to 'vigorously' defend Xifaxan patent litigation
3 years ago
Pharma
Which drugs may be hit with negotiations if the reconciliation bill passes? Wall St. analysts explain
3 years ago
Pharma
Manchin strikes again: Reconciliation package surfaces, with drug pricing reforms fully intact — for now
3 years ago
Pharma
First page
Previous page
30
31
32
33
34
35
36
Next page
Last page